VC incubator Accelerator Life Sciences launched its latest biotech startup Monday with a $30 million Series A investment from the likes of Pfizer, Eli Lilly and AbbVie.
Category: Forbes
The Egg Whisperer Is On A Crusade To Make People Aware Of Fertility Issues And Solutions
With many choosing to have children later in life, Dr. Aimee Eyvazzadeh is on a mission to share awareness of fertility issues — and potential solutions. Known to her clients as The Egg Whisperer, she educates and helps people preserve their fertility…
Obamacare Repeal A GOP Albatross As Midterm Elections Near
Democrats are hanging the Republican effort to repeal Obamacare around the necks of GOP Congressional candidates in this fall’s midterm elections.
Your Brain On Drama: What Social Media Means For Your Personal Growth
Neuroscience has a decent grasp on the ways our brain develops, processes stimuli and reacts to the world around us. But with each day, that world becomes noisier, more cluttered and chaotic. But to stop ugly, angry social media engagements, we have to…
Alnylam Prices First Gene Silencing Drug At $450,000 Per Patient, But Offers Money-Back Guarantee
This morning, after 16 years and $2.5 billion in investment, the Cambridge, Mass.-based company Alnylam finally turned a 1998 biology breakthrough into a medicine: a drug called Onpattro to treat the destruction of nerves that results from a rare disea…
Samsung’s Galaxy Note 9 Unsung Hero Feature Is Its Unique And Powerful DeX Dual Mode
There’s an enterprise market that Samsung is looking relatively well-position to tap into as well, as the company’s next generation Galaxy takes flight.
The Pressure Of Answering Work Emails At Night Takes Toll On Mental Health, Study Finds
Having to answer work emails off-hours is linked to stress, poorer health, and poorer relationships.
Personalized Medicine: A Culmination Of Everything The Digital Economy Has To Offer
With technology’s pervasiveness in all of our lives, we are beginning to experience what it’s like to live with a mobile doctor on hand.
Ample Partners For Rite Aid After End To Albertsons Deal
Rite Aid has ample opportunities to partner with health insurers and grow its EnvisionRx PBM into new Medicare Part D markets following the decision to end its merger with Albertsons.
Reducing Salt To Very Low Levels May Be Dangerous
A large new study offers powerful evidence that dramatic reductions in salt consumption may not be beneficial and might even prove harmful. In fact, the study suggests that too much salt in the dietis not a widespread global problem.
